Please assess the completion status of the following clinical trial:

Trial Title: Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in China

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Infants 6-12 months of age.~Exclusion Criteria:~* Prior Hib vaccine administration.~* History of serious reaction(s) following vaccination.~* Any vaccination within 14 days of study vaccination.~* Known or suspected immune impairment.~* For additional entry criteria please refer to the protocol.

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 12 Months
- Healthy Volunteers: t

Study Arms:
- Arm 1 (Type: ACTIVE_COMPARATOR): None
- Arm 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).